Therapeutic targets for type 2 diabetes post-UKPDS.
Yudkin
J S
JS
University College London. j.yudkin@ucl.ac.uk
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D001835:Body Weight; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000628:therapy; D006331:Heart Diseases / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D007003:Hypoglycemia / Q000150:complications; D008875:Middle Aged; D011446:Prospective Studies; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents